SCHEMBL5376574

SCHEMBL5376574

CCN(CC)C(=O)n1cnc(S(=O)(=O)Cc2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 1/20 0.39
FPR1 P21462 1/20 0.39
TLR9 Q9NR96 3/20 0.38
MEN1 O00255 2/20 0.38
HSP90AA1 P07900 2/20 0.38
KMT2A Q03164 2/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
MGLL Q99685 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
TSHR P16473 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376966 0.88 DAGLA (0.43) HSD17B10TLR9MEN1HSP90AA1KMT2A
SCHEMBL9550226 0.81 LMNA (0.46) LMNAALDH1A1OPRK1TSHRSMN1; SMN2
SCHEMBL9502987 0.81 ALDH1A1 (0.48) LMNAALDH1A1MEN1KMT2ATSHR
SCHEMBL10510171 0.80 DPP4 (0.39) LMNAALDH1A1KMT2AMGLLSMN1; SMN2
SCHEMBL9492475 0.79 MGLL (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL11375462 0.78 DPP4 (0.36) LMNAHSD17B10ALDH1A1MGLLTSHR
SCHEMBL8815291 0.78 LMNA (0.42) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL9544526 0.76 DPP4 (0.40) LMNAALDH1A1KMT2AMGLLSMN1; SMN2
SCHEMBL9015551 0.76 DPP4 (0.40) LMNAALDH1A1KMT2AMGLLSMN1; SMN2
SCHEMBL4897442 0.76 DPP4 (0.37) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4363915-A PRE-EMERGENT GULF OIL CORPORATION (US) 1982-12-14 US claimed
EP-0045566-A2 Benzylsulfonyl diethylcarbamyl triazole and use as a selective herbicide Gulf Oil Corporation (US) 1982-02-10 EP claimed
US-4280831-A Benzylsulfonyl diethylcarbamyl triazole and use as a selective herbicide GULF OIL CORPORATION (US) 1981-07-28 US claimed
JP-57058675-A None JP disclosed
US-7238720-B2 Pharmaceutical use of N-carbamoylazole derivatives EISAI R & D MANAGEMENT CO. LTD. (JP) 2007-07-03 US disclosed
US-7238720-B2 Pharmaceutical use of N-carbamoylazole derivatives EISAI R & D MANAGEMENT CO. LTD. (JP) 2007-07-03 US disclosed
EP-1258480-B1 Pharmaceutical use of N-Carbamoylazole derivatives EISAI CO LTD (JP) 2004-11-10 EP disclosed
EP-1258480-B1 Pharmaceutical use of N-Carbamoylazole derivatives EISAI CO LTD (JP) 2004-11-10 EP disclosed
US-20040186153-A1 Pharmaceutical use of N-carbamoylazole derivatives EISAI R & D MANAGEMENT CO. LTD. (JP) 2004-09-23 US disclosed
US-20030060494-A1 Pharmaceutical use of N-carbamoylazole derivatives EISAI CO., LTD. (JP) 2003-03-27 US disclosed
EP-1258480-A1 Pharmaceutical use of N-Carbamoylazole derivatives Eisai Co., Ltd. (JP) 2002-11-20 EP disclosed
US-6461997-B1 SUCH AS 3-(BROMODIFLUOROMETHYLSULFONYL)-1-(N,N-DIETHYL-CARBAMOYL)-1,2,4-TRIAZOLE; SELECTIVITY FOR WEEDS OVER CROPS; APPLY TO PLANTS OR SOIL MONSANTO TECHNOLOGY LLC 2002-10-08 US disclosed
US-5258361-A Antigrowth agents biological ROHM AND HAAS COMPANY (US) 1993-11-02 US disclosed
US-5211739-A Herbicidal-1-(disubstituted carbamoyl or thiocarbamoyl)-1,2,4-triazol-3-yl sulfonates and thisulfonates ROHM AND HAAS COMPANY (US) 1993-05-18 US disclosed
EP-0140194-B1 CARBAMOYLTRIAZOLES, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-02-01 EP disclosed
US-4363915-A PRE-EMERGENT GULF OIL CORPORATION (US) 1982-12-14 US disclosed
JP-S5758675-A HERBICIDAL 3-BENZYLSULFONYL-1-DIETHYLCARBAMOYL- 1,2,4-TRIAZOLE, HERBICIDAL COMPOSITION CONTAINING SAME AND USE GULF OIL CORP 1982-04-08 JP disclosed
US-4280831-A Benzylsulfonyl diethylcarbamyl triazole and use as a selective herbicide GULF OIL CORPORATION (US) 1981-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186153-A1 Pharmaceutical use of N-carbamoylazole derivatives DPP4, DPP3, DPP7 LMNA 4734/4885HSD17B10 1300/4885ALDH1A1 1026/4885
US-20030060494-A1 Pharmaceutical use of N-carbamoylazole derivatives DPP4, DPP3, DPP7 LMNA 4734/4885HSD17B10 1300/4885ALDH1A1 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.